Методологические аспекты лучевого лечения рака прямой кишки с использованием эндолюминальной высокомощностной адаптивной брахитерапии (опыт НМИЦ онкологии им. Н.Н. Петрова)

Методологические аспекты лучевого лечения рака прямой кишки с использованием эндолюминальной высокомощностной адаптивной брахитерапии (опыт НМИЦ онкологии им. Н.Н. Петрова)

Автор: Новиков Р.В., Тюряева Е.И., Арсеньев А.И., Пономарева О.И., Шишканова Ю.П., Сидорова А.Н., Ткаченко О.Б., Новиков С.Н.

Журнал: Вестник Российского научного центра рентгенорадиологии Минздрава России @vestnik-rncrr

Рубрика: Методическая статья. Лучевая терапия

Статья в выпуске: 3 т.23, 2023 года.

Бесплатный доступ

Целью работы является описание методики эндолюминальной высокомощностной адаптивной брахитерапии, проводимой в качестве неоадъювантного и неоперативного лечения рака прямой кишки (РПК). Отделение радиотерапии НМИЦ онкологии им. Н.Н. Петрова Минздрава обладает большим опытом брахитерапии опухолей различной локализации, в том числе РПК и рака анального канала. Использование методики началось в 2008 году и продолжается до настоящего времени. В статье освещена методология процедуры брахитерапевтического лечения и представлен обзор зарубежных публикаций, касающихся практических аспектов этой технологии.

Рак прямой кишки, неоперативное лечение, лучевая терапия, высокомощностная брахитерапия, энолюминальная брахитерапия, сочетанное лечение

Короткий адрес: https://sciup.org/149143502

IDR: 149143502

Список литературы Методологические аспекты лучевого лечения рака прямой кишки с использованием эндолюминальной высокомощностной адаптивной брахитерапии (опыт НМИЦ онкологии им. Н.Н. Петрова)

  • Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U Jr, Silva e Sousa AH Jr, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg. 2004 Oct;240(4):711-7; discussion 717-8. doi: 10.1097/01.sla.0000141194.27992.32.
  • Garcia-Aguilar J, Patil S, Gollub MJ, Kim JK, Yuval JB, Thompson HM, et al. Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy. J Clin Oncol. 2022 Aug 10;40(23):2546-2556. doi: 10.1200/JCO.22.00032.
  • Cerdán-Santacruz C, Vailati BB, São Julião GP, Habr-Gama A, Perez RO. Watch and wait: Why, to whom and how. Surg Oncol. 2022 Aug;43:101774. doi: 10.1016/j.suronc.2022.101774.
  • Xiao Y, Qiu M, Huang W, Hu S, Tan C, Nan F, et al. Global status of research on radiotherapy for rectal cancer: A bibliometric and visual analysis. Front Public Health. 2022 Aug 8;10:962256. doi: 10.3389/fpubh.2022.962256.
  • Benson AB, Venook AP, Al-Hawary MM, Arain MA, Chen YJ, Ciombor KK, et al. NCCN Guidelines Insights: Rectal Cancer, Version 6.2020. J Natl Compr Canc Netw. 2020 Jul;18(7):806-815. doi: 10.6004/jnccn.2020.0032.
  • Wo JY, Anker CJ, Ashman JB, Bhadkamkar NA, Bradfield L, Chang DT, et al. Radiation Therapy for Rectal Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. Pract Radiat Oncol. 2021 Jan-Feb;11(1):13-25. doi: 10.1016/j.prro.2020.08.004.
  • Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rödel C, Cervantes A, Arnold D; ESMO Guidelines Committee. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018 Oct 1;29(Suppl 4):iv263. doi: 10.1093/annonc/mdy161. Erratum for: Ann Oncol. 2017 Jul 1;28(suppl_4):iv22-iv40.
  • Chinese Watch & Wait Database Research Cooperation Group(CWWD); Chinese Association of Surgeons, Chinese Society of Coloproctology, Chinese Medical Doctor Association; Chinese Society of Colorectal Surgery, Chinese Medical Association; Colorectal Cancer Physician Specialty Committee, Chinese Medical Doctor Association; Radiation Therapy Specialty Committee, Chinese Anticancer Association. [Consensus on the Watch and Wait policy in rectal cancer patients after neoadjuvant treatment (2020 version)]. Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Jan 25;23(1):1-9. Chinese. doi: 10.3760/cma.j.issn.1671-0274.2020.01.001.
  • Podda M, Sylla P, Baiocchi G, Adamina M, Agnoletti V, Agresta F, et al. Multidisciplinary management of elderly patients with rectal cancer: recommendations from the SICG (Italian Society of Geriatric Surgery), SIFIPAC (Italian Society of Surgical Pathophysiology), SICE (Italian Society of Endoscopic Surgery and new technologies), and the WSES (World Society of Emergency Surgery) International Consensus Project. World J Emerg Surg. 2021 Jul 2;16(1):35. doi: 10.1186/s13017-021-00378-9.
  • Клинические рекомендации. Рак прямой кишки 2022. https://cr.minzdrav.gov.ru.
  • Dossa F, Chesney TR, Acuna SA, Baxter NN. A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2017 Jul;2(7):501-513. doi: 10.1016/S2468-1253(17)30074-2.
  • van der Valk MJM, Hilling DE, Bastiaannet E, Meershoek-Klein Kranenbarg E, Beets GL, et al; IWWD Consortium. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet. 2018 Jun 23;391(10139):2537-2545. doi: 10.1016/S0140-6736(18)31078-X.
  • Chadi SA, Malcomson L, Ensor J, Riley RD, Vaccaro CA, Rossi GL, et al. Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis. Lancet Gastroenterol Hepatol. 2018 Dec;3(12):825-836. doi: 10.1016/S2468-1253(18)30301-7.
  • Appelt A, Jakobsen A, Gerard JP, Sebag-Montefiore D. PH-0162: Is there a radiation dose-response relationship for non-operative management of rectal cancer? Radiother Oncol. 2020. Vol. 152: S76-S77. DOI:10.1016/S0167-8140(21)00186-9.
  • Michalski JM, Gay H, Jackson A, Tucker SL, Deasy JO. Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S123-9. doi: 10.1016/j.ijrobp.2009.03.078. Erratum in: Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):1185.
  • Fleischmann M, Diefenhardt M, Trommel M, Scherf C, Ramm U, Chatzikonstantinou G, et al. Image-guided high-dose-rate brachytherapy for rectal cancer: technical note and first clinical experience on an organ-preserving approach. Strahlenther Onkol. 2022 Jul;198(7):654-662. doi: 10.1007/s00066-022-01931-4.
  • Zhang SC, Atkins KM, Chung EM, Kamrava M. Emerging role of brachytherapy in the nonoperative management of rectal cancer. Curr Colorectal Cancer Rep. 2022;18:68-74. doi: 10.1007/s11888-022-00479-w.
  • Collard M, Lefevre JH. Ultimate Functional Preservation With Intersphincteric Resection for Rectal Cancer. Front Oncol. 2020 Mar 5;10:297. doi: 10.3389/fonc.2020.00297.
  • Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rödel C, Cervantes A, Arnold D; ESMO Guidelines Committee. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017 Jul 1;28(suppl_4):iv22-iv40. doi: 10.1093/annonc/mdx224. Erratum in: Ann Oncol. 2018 Oct 1;29(Suppl 4):iv263.
  • Stewart AJ, Van Limbergen EJ, Gerard JP, Appelt AL, Verhaegen F, Berbee M, et al. GEC ESTRO ACROP consensus recommendations for contact brachytherapy for rectal cancer. Clin Transl Radiat Oncol. 2021 Dec 11;33:15-22. doi: 10.1016/j.ctro.2021.12.004.
  • Gerard JP, Chapet O, Nemoz C, Hartweig J, Romestaing P, Coquard R, et al. Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the lyon R96-02 randomized trial. J Clin Oncol. 2004 Jun 15;22(12):2404-2409. doi: 10.1200/JCO.2004.08.170.
  • Fokas E, Glynne-Jones R, Fleischmann M, Piso P, Tselis N, Ghadimi M, et al. Radiotherapy dose escalation using endorectal brachytherapy in elderly and frail patients with rectal cancer unsuitable for surgery: Lessons from studies in fit patients and future perspectives. Cancer Treat Rev. 2023 Jan;112:102490. doi: 10.1016/j.ctrv.2022.102490.
  • Chadi SA, Malcomson L, Ensor J, Riley RD, Vaccaro CA, Rossi GL, et al. Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis. Lancet Gastroenterol Hepatol. 2018 Dec;3(12):825-836. doi: 10.1016/S2468-1253(18)30301-7.
  • Jankowski M, Pietrzak L, Rupiński M, Michalski W, Hołdakowska A, Paciorek K, et al; Polish Colorectal Study Group. Watch-and-wait strategy in rectal cancer: Is there a tumour size limit? Results from two pooled prospective studies. Radiother Oncol. 2021 Jul;160:229-235. doi: 10.1016/j.radonc.2021.05.014.
  • Hammarström K, Imam I, Mezheyeuski A, Ekström J, Sjöblom T, Glimelius B. A Comprehensive Evaluation of Associations Between Routinely Collected Staging Information and The Response to (Chemo)Radiotherapy in Rectal Cancer. Cancers (Basel). 2020 Dec 22;13(1):16. doi: 10.3390/cancers13010016.
  • Gérard JP, Chamorey E, Gourgou-Bourgade S, Benezery K, de Laroche G, Mahé MA, et al. Clinical complete response (cCR) after neoadjuvant chemoradiotherapy and conservative treatment in rectal cancer. Findings from the ACCORD 12/PRODIGE 2 randomized trial. Radiother Oncol. 2015 May;115(2):246-252. doi: 10.1016/j.radonc.2015.04.003.
  • Habr-Gama A, São Julião GP, Vailati BB, Fernandez LM, Ortega CD, Figueiredo N, et al. Organ Preservation Among Patients With Clinically Node-Positive Rectal Cancer: Is It Really More Dangerous? Dis Colon Rectum. 2019 Jun;62(6):675-683. doi: 10.1097/DCR.0000000000001337.
  • McCawley N, Clancy C, O'Neill BD, Deasy J, McNamara DA, Burke JP. Mucinous Rectal Adenocarcinoma Is Associated with a Poor Response to Neoadjuvant Chemoradiotherapy: A Systematic Review and Meta-analysis. Dis Colon Rectum. 2016 Dec;59(12):1200-1208. doi: 10.1097/DCR.0000000000000635.
  • Vuong T, Garant A, Vendrely V, Martin AG, Devic S. Clinical applications of high dose rate endorectal brachytherapy for patients with rectal cancer. Cancer Radiother. 2022 Oct;26(6-7):879-883. doi: 10.1016/j.canrad.2022.07.001.
  • Saraste D, Gunnarsson U, Janson M. Predicting lymph node metastases in early rectal cancer. Eur J Cancer. 2013 Mar;49(5):1104-1108. doi: 10.1016/j.ejca.2012.10.005.
  • The Royal College of Radiologists. National rectal cancer intensity-modulated radiotherapy (IMRT) guidance. London: The Royal College of Radiologists, 2021. Ref No. BFCO (21)1. www.rcr.ac.uk.
  • Verrijssen AS, Opbroek T, Bellezzo M, Fonseca GP, Verhaegen F, Gerard JP, et al. A systematic review comparing radiation toxicity after various endorectal techniques. Brachytherapy. 2019 Jan-Feb;18(1):71-86.e5. doi: 10.1016/j.brachy.2018.10.001. Epub 2018 Nov 3. Erratum in: Brachytherapy. 2019 May - Jun;18(3):427.
  • Garant A, Magnan S, Devic S, Martin AG, Boutros M, Vasilevsky CA, et al. Image Guided Adaptive Endorectal Brachytherapy in the Nonoperative Management of Patients With Rectal Cancer. Int J Radiat Oncol Biol Phys. 2019 Dec 1;105(5):1005-1011. doi: 10.1016/j.ijrobp.2019.08.042.
  • Rijkmans EC, Cats A, Nout RA, van den Bongard DHJG, Ketelaars M, Buijsen J, et al. Endorectal Brachytherapy Boost After External Beam Radiation Therapy in Elderly or Medically Inoperable Patients With Rectal Cancer: Primary Outcomes of the Phase 1 HERBERT Study. Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):908-917. doi: 10.1016/j.ijrobp.2017.01.033.
  • Buckley H, Wilson C, Ajithkumar T. High-Dose-Rate Brachytherapy in the Management of Operable Rectal Cancer: A Systematic Review. Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):111-127. doi: 10.1016/j.ijrobp.2017.05.023.
  • Bahadoer RR, Dijkstra EA, van Etten B, Marijnen CAM, Putter H, Kranenbarg EM, et al; RAPIDO collaborative investigators. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021 Jan;22(1):29-42. doi: 10.1016/S1470-2045(20)30555-6. Epub 2020 Dec 7. Erratum in: Lancet Oncol. 2021 Feb;22(2):e42.
  • Jin J, Tang Y, Hu C, Jiang LM, Jiang J, Li N, et al. Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR). J Clin Oncol. 2022 May 20;40(15):1681-1692. doi: 10.1200/JCO.21.01667.
  • Bujko K, Wyrwicz L, Rutkowski A, Malinowska M, Pietrzak L, Kryński J, et al; Polish Colorectal Study Group. Long-course oxaliplatin-based preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study. Ann Oncol. 2016 May;27(5):834-842. doi: 10.1093/annonc/mdw062.
  • Liao CK, Kuo YT, Lin YC, Chern YJ, Hsu YJ, Yu YL, et al. Neoadjuvant Short-Course Radiotherapy Followed by Consolidation Chemotherapy before Surgery for Treating Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis. Curr Oncol. 2022 May 19;29(5):3708-3727. doi: 10.3390/curroncol29050297.
  • Steinke J, Jordan C, Rossides S, Minnaar H, Yu J, Franklin A, et al. Planned organ preservation for elderly patients with rectal cancer using short course radiotherapy and a contact brachytherapy boost-an International multi-institution analysis. Clin Transl Radiat Oncol. 2023 Jan 11;39:100580. doi: 10.1016/j.ctro.2023.100580.
  • Van Limbergen E, Pötter R, Hoskin P, Baltas D (eds.). The GEC-ESTRO Handbook of Brachytherapy. 2nd edition. Clinical Practice Version 1 - 10/12/2014.
  • Myint AS, Dhadda AS, Stewart A, Mills J, Spiradam R, Rao C, et al. New hope from OPERA trial for surgically fit rectal cancer patients who wish to have organ preservation. Colorectal Dis. 2022. DOI: 10.1111/codi.16286.
  • Garant A, Vasilevsky CA, Boutros M, Khosrow-Khavar F, Kavan P, Diec H, et al. MORPHEUS Phase II-III Study: A Pre-Planned Interim Safety Analysis and Preliminary Results. Cancers (Basel). 2022 Jul 28;14(15):3665. doi: 10.3390/cancers14153665.
  • Rijkmans EC, Cats A, Nout RA, van den Bongard DHJG, Ketelaars M, Buijsen J, et al. Endorectal Brachytherapy Boost After External Beam Radiation Therapy in Elderly or Medically Inoperable Patients With Rectal Cancer: Primary Outcomes of the Phase 1 HERBERT Study. Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):908-917. doi: 10.1016/j.ijrobp.2017.01.033.
  • Corner C, Bryant L, Chapman C, Glynne-Jones R, Hoskin PJ. High-dose-rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma. Brachytherapy. 2010 Jan-Mar;9(1):66-70. doi: 10.1016/j.brachy.2009.07.004.
  • Vuong T, Devic S. High-dose-rate pre-operative endorectal brachytherapy for patients with rectal cancer. J Contemp Brachytherapy. 2015 Apr;7(2):183-8. doi: 10.5114/jcb.2015.51402.
  • Nout RA, Devic S, Niazi T, Wyse J, Boutros M, Pelsser V, Vuong T. CT-based adaptive high-dose-rate endorectal brachytherapy in the preoperative treatment of locally advanced rectal cancer: Technical and practical aspects. Brachytherapy. 2016 Jul-Aug;15(4):477-484. doi: 10.1016/j.brachy.2016.03.004.
  • Poon E, Reniers B, Devic S, Vuong T, Verhaegen F. Dosimetric characterization of a novel intracavitary mold applicator for 192Ir high dose rate endorectal brachytherapy treatment. Med Phys. 2006 Dec;33(12):4515-26. doi: 10.1118/1.2364054.
  • Fokas E, Appelt A, Glynne-Jones R, Beets G, Perez R, Garcia-Aguilar J, et al. International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer. Nat Rev Clin Oncol. 2021 Dec;18(12):805-816. doi: 10.1038/s41571-021-00538-5.
  • Gambacorta MA, Masciocchi C, Chiloiro G, Meldolesi E, Macchia G, van Soest J, et al. Timing to achieve the highest rate of pCR after preoperative radiochemotherapy in rectal cancer: a pooled analysis of 3085 patients from 7 randomized trials. Radiother Oncol. 2021 Jan;154:154-160. doi: 10.1016/j.radonc.2020.09.026.
  • Rupinski M, Szczepkowski M, Malinowska M, Mroz A, Pietrzak L, Wyrwicz L, et al. Watch and wait policy after preoperative radiotherapy for rectal cancer; management of residual lesions that appear clinically benign. Eur J Surg Oncol. 2016 Feb;42(2):288-296. doi: 10.1016/j.ejso.2015.09.022.
  • Habr-Gama A, Vianna MR, São Julião GP, Rawet V, Gama-Rodrigues J, Proscurshim I, et al. Management of adenomas within the area of rectal cancer that develop complete pathological response. Int J Colorectal Dis. 2015 Sep;30(9):1285-7. doi: 10.1007/s00384-015-2326-3.
Еще
Статья научная
SciUp 2024 © 2024 ©